Sana Biotechnology Inc (SANA) Company Profile & Statistics

Sana Biotechnology Inc
SANA
(Nasdaq - US)
N/A
10.36
+0.58 (+5.88%)
in:usd•As of: May 03, 2024 11:01 UTC -4
Open
10.13
High
10.47
Low
9.93

About Sana Biotechnology Inc

CEO

Steven D. Harr

Headquarters

188 east blaine street, suite 400

seattle, wa 98102, united states

Auditor

Ernst & Young LLP

Employees

328

Share Holders

Website

www.sana.com

Industry

biotechnology

Sector

health technology

Company Overview

Sana Biotechnology Inc. is focused on creating and delivering engineered cells as medicines for patients. The company involved in repairing and controlling genes, replacing missing or damaged cells as well as making its therapies. Sana Biotechnology Inc. is based in SEATTLE.

Sana Biotechnology Inc Statistics

Valuation Measures

Market Capitalization ²	2.28B
Enterprise Value	2.15B
Enterprise Value/EBITDA (ttm)	-8.00
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	6.60
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-88.36%
Return on Invested Capital (ttm)	-81.67%
Return on Assets (ttm)	-47.89%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-268.58M
Net Income Avi to Common (ttm)	-283.25M
Diluted EPS (ttm)	-1.47

Share Statistics

Beta (5Y Monthly)	1.62
52-Week Change	88.27%
S&P500 52-Week Change	26.16%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	220.45M
Dividend Yield	0.00%
Float ⁴	143.51M
% Held by Insiders	34.90%
% Held by Institutions	88.23%

Balance Sheet

Total Cash (mrq)	209.03M
Total Cash Per Share (mrq)	0.95
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	3.31%
Quick Ratio (mrq)	3.31%
Book Value Per Share (mrq)	1.45

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.30
Free Cash Flow (ytd)	-273.61M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Sana Biotechnology Inc

Trade With A Regulated Broker